Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT06070454
- Status
- Recruiting
Conditions
- Vaginitis
- Vulvar Diseases
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Vaginitis panel — DIAGNOSTIC_TESTvulvovaginal swab to test for the most common causes of vulvovaginitis - bacterial vaginosis (BV), trichomonas, and candida
Study Details
Primary: * To measure the rate of perioperative vulvovaginitis in a population of patients in central VA with non-malignant vulvar disease who require surgical excision * To correlate the rate of vulvovaginitis with rate of wound cellulitis and incisional breakdown in patients undergoing SPV/WLE for vulvar disease We will use a vulvovaginal swab to test for the most common causes of vulvovaginitis - bacterial vaginosis (BV), trichomonas, and candida. The swab will be collected preoperatively on day of surgery. The outcome will be evaluated by phone call to patient at 1 week after surgery and physical exam at the postoperative visit between 4-6 weeks.
Key Dates
- Start date
- Apr 25, 2024
- Status verified
- Oct 2025
- Primary completion
- Jun 1, 2026
- Completion
- Aug 1, 2026
Study Design
- Enrollment
- 91 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Positive Perioperative VaginitisParticipants who test positive for BV, candida, and/or trichomonas on perioperative vaginitis swab.
Primary Outcome Measure
the rate of perioperative vulvovaginitis [ Time Frame: 8 weeks ]
Central Contacts
- Amanda Urban434.409.3100
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22908 | Carrie Sopata, MD Carrie Sopata, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charlottesville, VA
Related Studies
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Marengo Therapeutics, Inc. · Loma Linda, California
- Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)PHASE2 · Recruiting · Frantz Viral Therapeutics, LLC · Fort Myers, Florida
- Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIVPHASE4 · Not Yet Recruiting · Albert Einstein College of Medicine · The Bronx, New York
- Large Algorithm Setting and Validation StudyNot Yet Recruiting · Nanopath, Inc · New Orleans, Louisiana